PharmExec Direct | From the editors of Pharmaceutical Executive
Send Us Some Feedback
 
JUNE 18 , 2009 | ISSUE NUMBER 100 VOL 5

Regulatory
Car Crashes, Sudden Deaths, and ADHD Meds Not Necessarily Related
Feds claim results of study comparing car crash deaths and children on ADHD drugs were not paramount to pulling kids off of ADHD treatments

Social Media
UCB Teams with PatientsLikeMe to Learn What Patients Want
UCB Teams with PatientsLikeMe to Learn What Patients Want DEK: In an effort to learn as more about epilepsy sufferers, UCB will implement a social network that allows patients to communicate about their disease state and treatments. Think of it as one giant, online clinical trial.

Strategy
Oscient Pharmaceuticals Lays Off 180 Reps
Oscient trims 180 sales, marketing, and corporate jobs in the wake of patent expirations, generic competition.

Pandemic
WHO Pushes H1N1 Flu to Pandemic State
The Word Health Organization bumped the H1N1 influenza to pandemic alert phase 6 (the highest alert level), making it the first worldwide pandemic in 41 years.

New Media
Games: The Next Frontier for Pharma Marketers
Can healthcare games change the game of healthcare? Ellen Hoenig Carlson of Advance MarketWoRx is live from Day 2 of the Games for Health Conference.

Global
Understanding the New World Order of Emerging Markets
Pharma is wrestling to understand the emerging markets will be the engine of growth for future sales.

Podcast
Celebrating Women of The Year—Laurie Cook and Ceci Zak
HBA’s CEO Laurie Cooke teams up with HBA President Ceci Zak to share how the Woman of the Year Award has changed the face of industry.

Worldwide intelligence-based advisory firm, Brendan Wood International, announced John C. Martin of Gilead Sciences, Shlomo Yanai of Teva Pharmaceutical, and Lars Rebien Soerensen of Novo Nordisk as “TopGun” CEO recipients // Catalent Pharma Solutions appointed Steve Leonard as senior vice president of global operations //ViroPharma appointed Frank Baldino to its board of directors//Epsilon announced that Alex Kooluris has joined Purple@Epsilon as vice president, general manager // Nektar Therapeutics promoted Lorianne Masuoka, M.D., to the position of chief medical officer// Vox Medica made Lorna Weir executive vice president/chief marketing Strategist and Donald Brogan senior vice president/practice leader, Education & Adult Learning // iZumi Bio appointed Corey S. Goodman to its board of directors and scientific advisory board // Astellas Pharma Global Development hired Dr. Peter Carberry as senior vice president and head of global development operations //ENCO Pharmaceutical Development appointed Keith Hurley vice president of sales and marketing


Advertisment

Free Educational Webcast Comparative Effectiveness

With President Obama calling for a national agency for comparative effectiveness and Congress introducing a bill in 2008 to set the stage at the federal level, no one doubts that comparative effectiveness is coming to healthcare. Join Tommy Bramley, senior director for Xcenda, and Tracy Foster, president for Lash Group on Thursday, June 25 at 2:00 PM (EDT) as they present on what these changes will encompass, how they will impact access to medications and what manufacturers can do to prepare.
Register Free at pharmexec.com/effectiveness

Webcasts

June 25 The Unvarnished Truth about Comparative Effectiveness
2:00 PM EST

July 8 Clinical Study Data Integration - the Art and the Promise
11:00 AM EST

June 17–19 American 2009 HCMA Conference, IN-AWE & Delta Awards, Newport, New Jersey

June 21–25 Drug Information Association 45th Annual Meeting, San Diego, CA

June 22–24 11th Annual Design for Six Sigma Excelling in Product Development 2009, Chicago, Illinois.

July 30–31 CBI’s 4th Clinical Supply Chain Management Conference, Princeton, NJ

September 21–24 5th Annual Process Excellence Week for the Service & Transactional World, Chicago, IL

October 5–7 BioNetwork 2009: The 7th Annual Pharmaceutical-Biotech Partnering Conference, Laguna Niguel, California


 
  FindPharma  
 
 

Survey
How would you rate the pharmaceutical industry's efforts to keep patients on their treatment regiments?
Click To Vote
Quick Links

Watson Pharma to Acquire Arrow Group for $1.75 Billion

NICE Recommends Roche's Leukemia Drug

GSK Battles with Russian Government

Merck Signs Discovery Deal with Xenon


Follow Pharm Exec on Twitter

User Management
| Subscribe | Update My Profile | Send Feedback | Advertise With Us | Visit PharmExec.com | Unsubscribe |

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit Pharmaceutical Executive Visit the PharmExec website